Nivolumab (anti-PD-1) [946414-94-4]

Selleck Chemicals

Nivolumab (anti-PD-1) [946414-94-4]

9

946414-94-4

Research Use Only

Nivolumab (anti-PD-1) is a genetically engineered, fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1,PCD-1) with immune checkpoint inhibitory and antineoplastic activities. MW : 143.597 KD.

12352200